|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:ANXA11-FFAR4 (FusionGDB2 ID:5007) |
Fusion Gene Summary for ANXA11-FFAR4 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ANXA11-FFAR4 | Fusion gene ID: 5007 | Hgene | Tgene | Gene symbol | ANXA11 | FFAR4 | Gene ID | 311 | 338557 |
| Gene name | annexin A11 | free fatty acid receptor 4 | |
| Synonyms | ALS23|ANX11|CAP-50|CAP50 | BMIQ10|GPR120|GPR129|GT01|O3FAR1|PGR4 | |
| Cytomap | 10q22.3 | 10q23.33 | |
| Type of gene | protein-coding | protein-coding | |
| Description | annexin A1156 kDa autoantigenannexin XIannexin-11calcyclin-associated annexin 50epididymis secretory sperm binding protein | free fatty acid receptor 4G-protein coupled receptor 120G-protein coupled receptor 129G-protein coupled receptor GT01G-protein coupled receptor PGR4omega-3 fatty acid receptor 1 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P50995 | Q5NUL3 | |
| Ensembl transtripts involved in fusion gene | ENST00000265447, ENST00000360615, ENST00000372231, ENST00000422982, ENST00000438331, ENST00000463657, ENST00000535999, ENST00000537102, | ENST00000371481, ENST00000371483, ENST00000604414, | |
| Fusion gene scores | * DoF score | 11 X 8 X 4=352 | 4 X 3 X 2=24 |
| # samples | 11 | 3 | |
| ** MAII score | log2(11/352*10)=-1.67807190511264 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/24*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: ANXA11 [Title/Abstract] AND FFAR4 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | ANXA11(81938999)-FFAR4(95346482), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ANXA11 | GO:0051592 | response to calcium ion | 9188810|12601007 |
| Tgene | FFAR4 | GO:0050872 | white fat cell differentiation | 31761534 |
| Fusion gene breakpoints across ANXA11 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across FFAR4 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS5.0 | N/A | BF859077 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
Top |
Fusion Gene ORF analysis for ANXA11-FFAR4 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000265447 | ENST00000371481 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000265447 | ENST00000371483 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000265447 | ENST00000604414 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000360615 | ENST00000371481 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000360615 | ENST00000371483 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000360615 | ENST00000604414 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000372231 | ENST00000371481 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000372231 | ENST00000371483 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000372231 | ENST00000604414 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000422982 | ENST00000371481 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000422982 | ENST00000371483 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000422982 | ENST00000604414 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000438331 | ENST00000371481 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000438331 | ENST00000371483 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000438331 | ENST00000604414 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000463657 | ENST00000371481 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000463657 | ENST00000371483 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000463657 | ENST00000604414 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000535999 | ENST00000371481 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000535999 | ENST00000371483 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000535999 | ENST00000604414 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000537102 | ENST00000371481 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000537102 | ENST00000371483 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| intron-intron | ENST00000537102 | ENST00000604414 | ANXA11 | chr10 | 81938999 | - | FFAR4 | chr10 | 95346482 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for ANXA11-FFAR4 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ANXA11-FFAR4 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:81938999/:95346482) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ANXA11 | FFAR4 |
| FUNCTION: Binds specifically to calcyclin in a calcium-dependent manner (By similarity). Required for midbody formation and completion of the terminal phase of cytokinesis. {ECO:0000250, ECO:0000269|PubMed:15197175}. | FUNCTION: [Isoform 2]: G-protein-coupled receptor for long-chain fatty acids (LCFAs) with a major role in adipogenesis, energy metabolism and inflammation. Signals via G-protein and beta-arrestin pathways (PubMed:22282525, PubMed:24742677, PubMed:27852822, PubMed:24817122, PubMed:22343897). LCFAs sensing initiates activation of phosphoinositidase C-linked G proteins GNAQ and GNA11 (G(q)/G(11)), inducing a variety of cellular responses via second messenger pathways such as intracellular calcium mobilization, modulation of cyclic adenosine monophosphate (cAMP) production, and mitogen-activated protein kinases (MAPKs) (PubMed:27852822, PubMed:22343897, PubMed:22282525, PubMed:24742677). After LCFAs binding, associates with beta-arrestin ARRB2 that acts as an adapter protein coupling the receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis (PubMed:22282525, PubMed:24817122). In response to dietary fats, plays an important role in the regulation of adipocyte proliferation and differentiation (By similarity). Acts as a receptor for omega-3 polyunsaturated fatty acids (PUFAs) at primary cilium of perivascular preadipocytes, initiating an adipogenic program via cAMP and CTCF-dependent chromatin remodeling that ultimately results in transcriptional activation of adipogenic genes and cell cycle entry (By similarity). Induces differentiation of brown adipocytes probably via autocrine and endocrine functions of FGF21 hormone (By similarity). Activates brown adipocytes by initiating intracellular calcium signaling that leads to mitochondrial depolarization and fission, and overall increased mitochondrial respiration (By similarity). Consequently stimulates fatty acid uptake and oxidation in mitochondria together with UCP1-mediated thermogenic respiration, eventually reducing fat mass (By similarity). Regulates bi-potential differentiation of bone marrow mesenchymal stem cells toward osteoblasts or adipocytes likely by up-regulating distinct integrins (By similarity). In response to dietary fats regulates hormone secretion and appetite (By similarity). Stimulates GIP and GLP1 secretion from enteroendocrine cells as well as GCG secretion in pancreatic alpha cells, thereby playing a role in the regulation of blood glucose levels (By similarity). Negatively regulates glucose-induced SST secretion in pancreatic delta cells (By similarity). Mediates LCFAs inhibition of GHRL secretion, an appetite-controlling hormone (By similarity). In taste buds, contributes to sensing of dietary fatty acids by the gustatory system (By similarity). During the inflammatory response, promotes anti-inflammatory M2 macrophage differentiation in adipose tissue (By similarity). Mediates the anti-inflammatory effects of omega-3 PUFAs via inhibition of NLRP3 inflammasome activation (PubMed:23809162). In this pathway, interacts with adapter protein ARRB2 and inhibits the priming step triggered by Toll-like receptors (TLRs) at the level of TAK1 and TAB1 (By similarity). Further inhibits the activation step when ARRB2 directly associates with NLRP3, leading to inhibition of proinflammatory cytokine release (PubMed:23809162). Mediates LCFAs anti-apoptotic effects (By similarity). {ECO:0000250|UniProtKB:Q7TMA4, ECO:0000269|PubMed:22282525, ECO:0000269|PubMed:22343897, ECO:0000269|PubMed:23809162, ECO:0000269|PubMed:24742677, ECO:0000269|PubMed:24817122, ECO:0000269|PubMed:27852822}.; FUNCTION: [Isoform 1]: Receptor for LCFAs decoupled from G-protein signaling. May signal through beta-arrestin pathway. After LCFAs binding, associates with beta-arrestin ARRB2 that may act as an adapter protein coupling the receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis. {ECO:0000269|PubMed:22282525}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for ANXA11-FFAR4 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for ANXA11-FFAR4 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ANXA11-FFAR4 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ANXA11-FFAR4 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies